M28 Capital Management as of Dec. 31, 2022
Portfolio Holdings for M28 Capital Management
M28 Capital Management holds 14 positions in its portfolio as reported in the December 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Wave Life Sciences SHS (WVE) | 39.4 | $41M | 5.9M | 7.00 | |
| Rocket Pharmaceuticals (RCKT) | 13.5 | $14M | 722k | 19.57 | |
| Adagio Therapeutics (IVVD) | 13.2 | $14M | 9.2M | 1.50 | |
| Proqr Thrapeutics N V Shs Euro (PRQR) | 6.7 | $7.1M | 1.9M | 3.70 | |
| Arrowhead Pharmaceuticals (ARWR) | 5.6 | $5.8M | 144k | 40.56 | |
| Ionis Pharmaceuticals (IONS) | 4.5 | $4.8M | 126k | 37.77 | |
| Stoke Therapeutics (STOK) | 4.2 | $4.5M | 483k | 9.23 | |
| Bridgebio Pharma (BBIO) | 3.0 | $3.2M | 419k | 7.62 | |
| Springworks Therapeutics (SWTX) | 2.7 | $2.9M | 110k | 26.01 | |
| Curis Com New | 2.3 | $2.5M | 4.5M | 0.55 | |
| Silence Therapeutics Ads (SLN) | 2.1 | $2.2M | 146k | 15.25 | |
| Atara Biotherapeutics | 1.4 | $1.4M | 439k | 3.28 | |
| Tg Therapeutics (TGTX) | 1.2 | $1.2M | 104k | 11.83 | |
| Neximmune | 0.0 | $32k | 133k | 0.24 |
